Prediabetes is Associated with Worse Long-Term Outcomes in Young Patients with Acute Coronary Syndrome

References

• Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med. 1984;311(18):1144–1147. doi:10.1056/NEJM198411013111802
   PubMed Web of Science ®Google Scholar
• Han T, Wang Q, Yang H, et al. Risk factors for repeat percutaneous coronary intervention in young patients (≤45 years of age) with acute coronary syndrome. PeerJ. 2019;7:e6804. doi:10.7717/peerj.6804
   PubMed Web of Science ®Google Scholar
• Yandrapalli S, Nabors C, Goyal A, et al. Modifiable risk factors in young adults with first myocardial infarction. J Am Coll Cardiol. 2019;73(5):573–584. doi:10.1016/j.jacc.2018.10.084
   PubMed Web of Science ®Google Scholar
• Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215–2221. doi:10.1016/S0140-6736(09)60619-X
   PubMed Web of Science ®Google Scholar
• Colagiuri S. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. Eur Heart J. 2004;25(21):1861–1862. doi:10.1016/j.ehj.2004.09.002
   PubMed Web of Science ®Google Scholar
• Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359(9324):2140–2144. doi:10.1016/S0140-6736(02)09089-X
   PubMed Web of Science ®Google Scholar
• Hollander P, Spellman C. Controversies in prediabetes: do we have a diagnosis? Postgrad Med. 2012;124(4):109–118. doi:10.3810/pgm.2012.07.2562
   PubMed Web of Science ®Google Scholar
• Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. doi:10.1093/eurheartj/ehz486
   PubMed Web of Science ®Google Scholar
• Balakrishnan R, Berger JS, Tully L, et al. Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention. Diabetes Metab Res Rev. 2015;31(6):603–609. doi:10.1002/dmrr.2646
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, George A, John J, et al. Pre-diabetes mellitus newly diagnosed after myocardial infarction adversely affects prognosis in patients without known diabetes. Diab Vasc Dis Res. 2019;16(6):489–497. doi:10.1177/1479164119845561
   PubMed Web of Science ®Google Scholar
• He Y, Lu H, Ling Y, et al. Prediabetes and all-cause mortality in young patients undergoing coronary artery angiography: a multicenter cohort study in China. Cardiovasc Diabetol. 2023;22(1):42. doi:10.1186/s12933-023-01776-w
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. classification and diagnosis of diabetes: standards of medical care in diabetes–2019. Diabetes Care. 2019;42(Supplement_1):S13–S28. doi:10.2337/dc19-S002
   PubMedGoogle Scholar
• Echouffo-Tcheugui JB, Perreault L, Ji L, et al. Diagnosis and management of prediabetes: a review. JAMA. 2023;329(14):1206–1216. doi:10.1001/jama.2023.4063
   PubMed Web of Science ®Google Scholar
• Hermanides RS, Kennedy MW, Kedhi E, et al. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a ‘real world’ prospective registry of the Zwolle Myocardial Infarction Study Group. Eur Heart J Acute Cardiovasc Care. 2020;9(6):616–625. doi:10.1177/2048872619849921
   PubMed Web of Science ®Google Scholar
• Timmer JR, Hoekstra M, Nijsten MW, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation. 2011;124(6):704–711. doi:10.1161/CIRCULATIONAHA.110.985911
   PubMed Web of Science ®Google Scholar
• Mahendran DC, Hamilton G, Weiss J, et al. Prevalence of pre-existing dysglycaemia among inpatients with acute coronary syndrome and associations with outcomes. Diabetes Res Clin Pract. 2019;154:130–137. doi:10.1016/j.diabres.2019.07.002
   PubMed Web of Science ®Google Scholar
• Gao S, Ma W, Huang S, et al. Impact of prediabetes on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries. Diabetol Metab Syndr. 2021;13(1):103. doi:10.1186/s13098-021-00721-9
   PubMed Web of Science ®Google Scholar
• Giraldez RR, Clare RM, Lopes RD, et al. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. Am Heart J. 2013;165(6):918–25.e2. doi:10.1016/j.ahj.2013.01.005
   PubMed Web of Science ®Google Scholar
• Xue M, Dutton H, Arnaout A. Effects of prediabetes on long-term risk of developing cardiac events in patients presenting with acute coronary syndrome. Can J Diabetes. 2023;47(6):490–496. doi:10.1016/j.jcjd.2023.04.014
   PubMed Web of Science ®Google Scholar
• Åkerblom A, Wojdyla D, Steg PG, et al. Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. J Thromb Thrombolysis. 2019;48(4):563–569. doi:10.1007/s11239-019-01938-2
   PubMed Web of Science ®Google Scholar
• Kiviniemi AM, Lepojärvi ES, Tulppo MP, et al. Prediabetes and risk for cardiac death among patients with coronary artery disease: the ARTEMIS Study. Diabetes Care. 2019;42(7):1319–1325. doi:10.2337/dc18-2549
   PubMed Web of Science ®Google Scholar
• Farhan S, Redfors B, Maehara A, et al. Impact of pre-diabetes on coronary plaque composition and clinical outcome in patients with acute coronary syndromes: an analysis from the PROSPECT study. JACC Cardiovasc Imaging. 2019;12(4):733–741. doi:10.1016/j.jcmg.2017.06.023
   PubMed Web of Science ®Google Scholar
• Li Y, Woo V, Bose R. Platelet hyperactivity and abnormal Ca 2+ homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol. 2001;280(4):H1480–H1489. doi:10.1152/ajpheart.2001.280.4.H1480
   PubMed Web of Science ®Google Scholar
• Inoue T, Croce K, Morooka T, et al. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv. 2011;4(10):1057–1066. doi:10.1016/j.jcin.2011.05.025
   PubMed Web of Science ®Google Scholar
• Amano T, Matsubara T, Uetani T, et al. Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. JACC Cardiovasc Imaging. 2008;1(1):39–45. doi:10.1016/j.jcmg.2007.09.003
   PubMed Web of Science ®Google Scholar
• Ertan C, Ozeke O, Gul M, et al. Association of prediabetes with diffuse coronary narrowing and small-vessel disease. J Cardiol. 2014;63(1):29–34. doi:10.1016/j.jjcc.2013.06.015
   PubMed Web of Science ®Google Scholar
• Vistisen D, Kivimäki M, Perreault L, et al. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study. Diabetologia. 2019;62(8):1385–1390. doi:10.1007/s00125-019-4895-0
   PubMed Web of Science ®Google Scholar
• Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–1686.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–759. doi:10.2337/dc07-9920
   PubMed Web of Science ®Google Scholar